The Shotlee Journal
Browse Shotlee articles about Mounjaro.
Showing 9 / 801 Mounjaro articles
GLP-1 medications like Ozempic are transforming lives but also sparking a spending frenzy far beyond drug costs. From gym memberships to combat muscle loss to entire wardrobe replacements, users like sales executive Kelly Freeman are spending $700-$1,000 monthly. Industries from fitness to plastic surgery are reaping windfalls.
Rosie O'Donnell, who started Mounjaro in January 2023 for diabetes management, has become a poster child for 'Mounjaro face' after shedding 10 pounds quickly. Side-by-side photos from September 2022 and October 2025 highlight sagging skin around her mouth and cheeks, with expert analysis noting a grayish hue. Despite cosmetic changes, she's embracing the weight loss benefits.
Real Housewives of Salt Lake City star Heather Gay has shared her Ozempic-assisted weight loss journey, crediting the GLP-1 injection for noticeable results after initial slow progress. Losing around 30 pounds amid social pressures from friends' transformations, she called it a 'long, overdue glow-up' thanks to modern medicine. Despite Ozempic face rumors, Gay remains open about her experience.
Cheaper generic semaglutide is transforming access to weight loss and diabetes treatment in India, priced at just Rs750 per weekly injection. However, experts caution against 'quick-fix' use without medical oversight, highlighting risks like 40% muscle loss from lean mass. Discover clinical evidence from STEP-1 and SELECT trials and why structured care is essential.
Wegovy, Ozempic, and Mounjaro promise effortless weight loss with minimal risk, but new research uncovers deeper dangers like altered brain chemistry and loss of desire. On The Spectacle Podcast, Scott McKay and Melissa Mackenzie dive into the science, Melissa's personal story, and why lifestyle changes offer a safer path.
Novo Nordisk has won EU regulatory approval to ease cold chain requirements for Wegovy injections, marking the first GLP-1 therapy in Europe with such delivery flexibility. The change allows a 48-hour window without refrigeration from pharmacies to patients, streamlining distribution and enhancing access. This aligns with trends in direct-to-patient models and complements recent subscription programs for better affordability.
America faces a crisis in unregulated compounded GLP-1 drugs, with FDA reporting 1,150 adverse events including hospitalizations and deaths. Exploiting shortages of semaglutide and tirzepatide, compounders flood the market with untested products, misleading consumers. Now, with the SAFE Drugs Act and FDA crackdowns, it's time to restore safety standards.
Roughly half a million Australians are using GLP-1 weight loss drugs like Ozempic and Mounjaro, with some reporting life-changing results while others face side effects. Professor Kelly Lambert from the University of Wollongong shares key insights on what you need to know. This guide covers mechanisms, safety, and practical tips for users.
GLP-1 weight-loss drugs like Ozempic are transforming beauty retail, with Ulta CEO Kecia Steelman spotting huge opportunities in 'Ozempic face' and hair thinning. Over 40 million prescriptions in 2024 signal a booming market for volumizing shampoos and firming creams. Here's how Ulta is capitalizing on this shift.
